세계의 제네릭 의약품 시장 기회와 전략(-2033년)

Generic pharmaceuticals are copies of known brand-name drugs that have exactly the same dosage, intended use, effects, side effects, route of administration, risks, safety and strength as the original drug. Their pharmacological effects are exactly the same as those of their brand-name counterparts. An example of a generic drug used for diabetes, is Metformin. The brand name for Metformin is Glucophage. A generic drug used for Hypertension, is Metoprolol, whereas the brand name for the same drug is Lopressor.

The generic pharmaceuticals market consists of sales, by entities (organizations, sole traders and partnerships), of generic pharmaceuticals products.

The global generic pharmaceuticals market was valued at $289,292.74 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 7.00%.

Increased Number Of Surgical Procedures

The increased number of surgical procedures boosted the growth of the generic pharmaceuticals market during the historic period. The increased number of surgical procedures drove demand for cost-effective medications needed during and after operations. With rising interventions, the need for anesthetics, pain management drugs and antibiotics, many of which are available as generics, has surged. Healthcare providers are increasingly choosing generics to reduce costs without sacrificing care, enhancing accessibility. This trend, particularly in outpatient settings, supports efforts to lower healthcare spending while ensuring effective treatment options, thus propelling market growth. For instance, according to the Global Survey on Aesthetic/Cosmetic Procedures by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, there was an 11.2% increase in procedures performed by plastic surgeons in 2022, totaling over 14.9 million surgical and 18.8 million non-surgical procedures globally. The report highlights a significant rise in aesthetic surgery, with a 41.3% increase over the past four years. Both categories have shown growth since the last survey, with surgical procedures increasing by 16.7% and non-surgical procedures by 7.2%, including a remarkable 57.8% rise in non-surgical procedures over the same period. Additionally, according to Novascotia.ca, the official website for the province of Nova Scotia, Canada, in the 2022-2023 fiscal year, there were 1,873 more surgeries performed compared to 2019-20, along with 4,863 additional endoscopy and cystoscopy procedures. Notably, outpatient hip and knee replacement surgeries surged to 1,193 in 2022-23 from just 85 in 2019-20, allowing patients to recover at home and freeing up hospital beds for other patients. Therefore, the increased number of surgical procedures contributed to the growth of the generic pharmaceuticals market.

Introduction Of Innovative Ready-To-Use Injectable Formulations To Enhance Patient Convenience In Chemotherapy Regimens

Generic pharmaceuticals manufacturers are introducing innovative ready-to-use injectable formulations to improve patient convenience in chemotherapy regimens. These products eliminate the need for reconstitution or dilution, enabling quick and efficient medication administration by healthcare providers. By simplifying preparation, they enhance patient experience and adherence to treatment protocols while aiding in the effective management of chemotherapy-related side effects, such as nausea and vomiting, ultimately promoting more comfortable care for cancer patients. For instance, in July 2024, Amneal Pharmaceuticals, Inc., a US-based generics and specialty pharmaceutical company, and Steriscience Specialties Private Limited, an India-based pharmaceutical company, launched FOCINVEZ, a ready-to-use injectable formulation of fosaprepitant. This single-dose vial product is unique as it is free of Polysorbate 80 and does not require reconstitution or dilution, allowing for direct administration using the included vial hanger. FOCINVEZ is indicated for adults and pediatric patients aged six months and older in combination with other antiemetic agents to prevent acute and delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy, including high-dose cisplatin.

The global generic pharmaceuticals market is fairly fragmented, with a large number of small players in the market. The top ten competitors in the market made up to 10.31% of the total market in 2023.

Generic Pharmaceuticals Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global generic pharmaceuticals market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for generic pharmaceuticals? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The generic pharmaceuticals market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider generic pharmaceuticals market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by drug delivery, by therapy and by distribution channel.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the generic pharmaceuticals market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by drug delivery, by therapy and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for generic pharmaceuticals providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Type: Biosimilars; Generics
• 2) By Therapy: Oncology Drugs; Central Nervous System Drugs; Anti-Infective Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Others
• 3) By Drug Delivery: Oral; Injectables; Dermal/Topical; Other Drug Delivery
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Sandoz Group AG; Sun Pharmaceutical Industries Ltd.; Viatris Inc.; Abbott Laboratories
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; generic pharmaceuticals indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Generic Pharmaceuticals - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Generic Pharmaceuticals Market Definition And Segmentations
• 6.4 Market Segmentation By Type
  • 6.4.1 Biosimilar
  • 6.4.2 Generics
• 6.5 Market Segmentation By Drug Delivery
  • 6.5.1 Oral
  • 6.5.2 Injectables
  • 6.5.3 Dermal/Topical
  • 6.5.4 Other Drug Delivery
• 6.6 Market Segmentation By Therapy
  • 6.6.1 Oncology Drugs
  • 6.6.2 Central Nervous System (CNS) Drugs
  • 6.6.3 Anti-Infective Drugs
  • 6.6.4 Respiratory Diseases Drugs
  • 6.6.5 Cardiovascular Drugs
  • 6.6.6 Metabolic Disorders Drugs
  • 6.6.7 Musculoskeletal Disorders Drugs
  • 6.6.8 Others
• 6.7 Market Segmentation By Distribution Channel
  • 6.7.1 Hospital Pharmacies
  • 6.7.2 Retail Pharmacies
  • 6.7.3 Online Pharmacies

7 Major Market Trends

• 7.1 Launch Of New Generic Pharmaceuticals To Broaden Patient Access To Essential Therapeutics Across Diverse Health Conditions
• 7.2 Introduction Of Innovative Ready-To-Use Injectable Formulations To Enhance Patient Convenience In Chemotherapy Regimens
• 7.3 Strategic Partnerships And Collaborations Among Major Players To Enhance Product Offerings
• 7.4 Strategic Launch Of Generic Oral Solutions To Enhance Market Competitiveness And Patient Access To Essential Medications

8 Generic Pharmaceuticals Market - Macro-Economic Scenario

• 8.1 COVID-19 Impact On The Generic Pharmaceuticals Market
• 8.2 Impact Of The War In Ukraine On The Generic Pharmaceuticals Market
• 8.3 Impact Of High Inflation On The Generic Pharmaceuticals Market

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Generic Pharmaceuticals Market Segmentation

• 10.1 Global Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.4 Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Generic Pharmaceuticals Market, Regional and Country Analysis

• 11.1 Global Generic Pharmaceuticals Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Generic Pharmaceuticals Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate Tax Structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.6 China Market
• 12.7 Summary
• 12.8 Market Overview
  • 12.8.1 Country Information
  • 12.8.2 Market Information
  • 12.8.3 Background Information
  • 12.8.4 Government Initiatives
  • 12.8.5 Regulations
  • 12.8.6 Regulatory Bodies
  • 12.8.7 Major Associations
  • 12.8.8 Taxes Levied
  • 12.8.9 Corporate Tax Structure
  • 12.8.10 Investments
  • 12.8.11 Major Companies
• 12.9 China Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.10 China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.12 India Market
• 12.13 India Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.14 India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.16 Japan Market
• 12.17 Japan Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.18 Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.20 Australia Market
• 12.21 Australia Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.22 Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.24 Indonesia Market
• 12.25 Indonesia Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.26 Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.28 South Korea Market
• 12.29 South Korea Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.30 South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.31 South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Investments
  • 13.2.11 Major Companies
• 13.3 Western Europe Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.6 Western Europe Generic Pharmaceuticals Market: Country Analysis
• 13.7 UK Market
• 13.8 UK Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.11 Germany Market
• 13.12 Germany Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.15 France Market
• 13.16 France Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.19 Italy Market
• 13.20 Italy Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Italy Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.23 Spain Market
• 13.24 Spain Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.26 Spain Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Investments
  • 14.2.11 Major Companies
• 14.3 Eastern Europe Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.6 Eastern Europe Generic Pharmaceuticals Market: Country Analysis
• 14.7 Russia Market
• 14.8 Russia Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.10 Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Investments
  • 15.2.11 Major Companies
• 15.3 North America Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.6 North America Generic Pharmaceuticals Market: Country Analysis
• 15.7 USA Market
• 15.8 Summary
• 15.9 Market Overview
  • 15.9.1 Country Information
  • 15.9.2 Market Information
  • 15.9.3 Background Information
  • 15.9.4 Government Initiatives
  • 15.9.5 Regulations
  • 15.9.6 Regulatory Bodies
  • 15.9.7 Major Associations
  • 15.9.8 Taxes Levied
  • 15.9.9 Corporate Tax Structure
  • 15.9.10 Investments
  • 15.9.11 Major Companies
• 15.10 USA Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.12 USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada Market
• 15.14 Canada Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.15 Canada Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.16 Canada Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Investments
  • 16.2.11 Major Companies
• 16.3 South America Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.6 South America Generic Pharmaceuticals Market: Country Analysis
• 16.7 Brazil Market
• 16.8 Brazil Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.10 Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Investments
  • 17.2.11 Major Companies
• 17.3 Middle East Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.5 Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
• 18.2 Market Overview
  • 18.2.1 Region Information
  • 18.2.2 Market Information
  • 18.2.3 Background Information
  • 18.2.4 Government Initiatives
  • 18.2.5 Regulations
  • 18.2.6 Regulatory Bodies
  • 18.2.7 Major Associations
  • 18.2.8 Taxes Levied
  • 18.2.9 Corporate Tax Structure
  • 18.2.10 Investments
  • 18.2.11 Major Companies
• 18.3 Africa Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.5 Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape and Company Profiles

• 19.1 Company Profiles
• 19.2 Teva Pharmaceutical Industries Ltd
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 Sandoz Group AG
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 Sun Pharmaceutical Industries Ltd
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Viatris Inc
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 Abbott Laboratories
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Financial Overview

20 Other Major And Innovative Companies

• 20.1 Dr. Reddy's Laboratories
  • 20.1.1 Company Overview
  • 20.1.2 Products And Services
• 20.2 Cipla Limited
  • 20.2.1 Company Overview
  • 20.2.2 Products And Services
• 20.3 Fresenius Kabi AG
  • 20.3.1 Company Overview
  • 20.3.2 Products And Services
• 20.4 Zydus Lifesciences Limited
  • 20.4.1 Company Overview
  • 20.4.2 Products And Services
• 20.5 Stada Arzneimittel AG
  • 20.5.1 Company Overview
  • 20.5.2 Products And Services
• 20.6 Lupin Inc
  • 20.6.1 Company Overview
  • 20.6.2 Products And Services
• 20.7 Alkem Laboratories Ltd
  • 20.7.1 Company Overview
  • 20.7.2 Products And Services
• 20.8 Amneal Pharmaceuticals, Inc
  • 20.8.1 Company Overview
  • 20.8.2 Products And Services
• 20.9 Torrent Pharmaceuticals Ltd
  • 20.9.1 Company Overview
  • 20.9.2 Products And Services
• 20.1 Sawai Group Holdings Co., Ltd
  • 20.10.1 Company Overview
  • 20.10.2 Products And Services
• 20.11 Sanofi S.A.
  • 20.11.1 Company Overview
  • 20.11.2 Products And Services
• 20.12 Hikma Pharmaceuticals PLC
  • 20.12.1 Company Overview
  • 20.12.2 Products And Services
• 20.13 Aurobindo Pharma Limited
  • 20.13.1 Company Overview
  • 20.13.2 Products And Services
• 20.14 Aspen Pharmacare Holdings Ltd
  • 20.14.1 Company Overview
  • 20.14.2 Products And Services
• 20.15 Endo International plc
  • 20.15.1 Company Overview
  • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

• 23.1 Farmak Pharmaceuticals UK Ltd. Acquired A&S Pharma Holdings
• 23.2 Platinum Equity Acquired A Majority Stake In Inventia Healthcare Limited
• 23.3 Lotus Pharmaceuticals Acquired Teva Pharma Thailand
• 23.4 Apotex Acquired Searchlight Pharma
• 23.5 Genpharmasec Limited Acquired A Majority Stake In DHPL
• 23.6 Lupin Limited Acquired Medisol
• 23.7 Sun Pharmaceutical Industries Ltd. Acquired Taro Pharmaceutical Industries Ltd.
• 23.8 Dr. Reddy's Laboratories Acquired Mayne Pharma's US Generic Prescription Product Portfolio
• 23.9 Dr. Reddy's Laboratories Acquired Eton's Branded And Generic Injectable Products Portfolio

24 Opportunities And Strategies

• 24.1 Global Generic Pharmaceuticals Market In 2028 - Countries Offering Most New Opportunities
• 24.2 Global Generic Pharmaceuticals Market In 2028 - Segments Offering Most New Opportunities
• 24.3 Global Generic Pharmaceuticals Market In 2028 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Generic Pharmaceuticals Market Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer